Among the affected products are eye ointments, dry-eye relief eyedrops and preservative-free eyedrops.
“Administration of a nonsterile product intended to be sterile may result in serious and potentially life-threatening infections or death,” the recall notice reads.
Access the full list of affected products here.
More articles on pharmacy:
Judge blocks HHS rule requiring drug prices in TV ads
Nation’s 1st prescription drug affordability board goes into effect
11 healthcare pharma leaders offer advice on controlling drug spend
